CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study-Reference-Cited by-同舟云学术

CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study

Published:2017-04 Issue:4 Volume:19 Page:531-542
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Jaiswal Sarita Rani,Zaman Shamsur,Nedunchezhian Murugaiyan,Chakrabarti Aditi,Bhakuni Prakash,Ahmed Margoob,Sharma Kanika,Rawat Sheh,O'donnell Paul,Chakrabarti Suparno

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference36 articles.

1. Haploidentical stem cell transplantation in adult haematological malignancies;Parmesar;Adv Hematol,2016

2. Choice of Unmanipulated t cell replete graft for haploidentical stem cell transplant and posttransplant cyclophosphamide in hematologic malignancies in adults: peripheral blood or bone marrow-review of published literature;Farhan;Adv Hematol,2016

3. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide;McCurdy;Blood,2015

4. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index

5. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning;Raiola;Biol Blood Marrow Transplant,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients;Bone Marrow Transplantation;2024-08-12

2. Future directions in haploidentical hematopoietic stem cell transplantation;Hematology;2024-06-18

3. Adoptive cellular therapy after hematopoietic stem cell transplantation;American Journal of Hematology;2024-01-25

4. Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML;Frontiers in Immunology;2023-08-15

5. Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease;Frontiers in Hematology;2023-08-03